Fig. 6
From: Neural progenitor cell-derived exosomes in ischemia/reperfusion injury in cardiomyoblasts
Western blot. A1 and A2 are gels from the samples 1–8, B1 and B2 are gels from samples 9–16, and sample17 is technical control showing positive for calnexin at 90 kDa (negative antibody control, B1, line 17) and TSG101 at 25 kDa (positive control, B2, line 17). L stands for ladder. 1 = Bioreactor 20k, 2 = Bioreactor 110k, 3 = Neurosphere 20k, 4 = Neurosphere 110k, 5 = Adherent cells 20k, 6 = Adherent cells 110k, 7 = Bioreactor 20k, 8 = Bioreactor 110k, 9 = Adherent cells 20k, 10 = Adherent cells 110k, 11 = Neurospheres 20k, 12 = Neurospheres 110k, 13 = Bioreactor 20k, 14 = Bioreactor 110k, 15 = Neurosphere 20k, 16 = Neurosphere 110k, 17 = control. Only three samples of our exosomes returned positive findings in Western blot analysis. These were labeled as our study groups as follows: 12 = Exo 1 Neurospheres 110k, 14 = Exo 2 Bioreactor 110k and 16 = Exo 3 Neurospheres 110k